Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21120517 | 0.79 | ESR1 (0.38) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL15184948 | 0.79 | — | — | |
| SCHEMBL988384 | 0.78 | NR1H2 (0.48) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL15889153 | 0.78 | ESR1 (0.41) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL25798859 | 0.77 | MAPK1 (0.41) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL10569078 | 0.76 | ESR1 (0.39) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL104796 | 0.76 | NR1H2 (0.45) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL17576282 | 0.75 | ESR1 (0.35) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL3526796 | 0.74 | ESR1 (0.37) | ESR1ESR2NR1H2NR1H3MAPK1 | |
| SCHEMBL29749402 | 0.74 | ESR1 (0.37) | ESR1ESR2NR1H2NR1H3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | SIGMA COATINGS B.V. (NL) | 2006-06-29 | — | — | US | claimed |
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | INSTITUT PASTEUR (FR) | 2024-01-25 | — | — | US | disclosed |
| US-20230347587-A1 | 3-D PRINTING | PERIDOT PRINT LLC | 2023-11-02 | — | — | US | disclosed |
| WO-2023189484-A1 | INK COMPOSITION FOR ELECTRO-OPTIC APPLICATIONS, COMPOUND, ELECTRO-OPTIC FILM AND ELECTRO-OPTIC ELEMENT | 住友化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023192900-A1 | NUCLEOSIDES AND NUCLEOTIDES WITH 3' VINYL BLOCKING GROUP USEFUL IN SEQUENCING BY SYNTHESIS | ILLUMINA SINGAPORE PTE. LTD. (SG) | 2023-10-05 | — | — | WO | disclosed |
| EP-4247828-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | Institut Pasteur (FR) | 2023-09-27 | — | — | EP | disclosed |
| US-11718024-B2 | 3-D printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-08-08 | — | — | US | disclosed |
| US-11718024-B2 | 3-D printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-08-08 | — | — | US | disclosed |
| US-20230233692-A1 | COMPOUNDS FOR TARGETED DEGRADATION OF RET | C4 THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | US | disclosed |
| US-11700765-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
| US-20120301817-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM USING THE COMPOSITION AND PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20110288053-A1 | ANTIVIRAL PHOSPHONATE ANALOGS | GILEAD SCIENCES, INC. (US) | 2011-11-24 | — | — | US | disclosed |
| US-20110269707-A1 | Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation | PHARMASSET, INC. | 2011-11-03 | — | — | US | disclosed |
| US-20110071101-A1 | Nucleoside Phosphonate Analogs | BOOJAMRA CONSTANTINE G | 2011-03-24 | — | — | US | disclosed |
| US-20110039209-A1 | COMPOUND AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20100144868-A1 | Novel Neuroprotective Compounds and Uses Thereof | RAMOT AT AVIV UNIVERSITY LTD. (IL) | 2010-06-10 | — | — | US | disclosed |
| CN-101072757-A | Benzamide derivatives that act upon the glucokinase enzyme | ASTRAZENECA AB (SE) | 2007-11-14 | — | — | CN | disclosed |
| CN-101039915-A | Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity | ASTRAZENECA AB (SE) | 2007-09-19 | — | — | CN | disclosed |
| EP-1389214-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002094838-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071101-A1 | Nucleoside Phosphonate Analogs | TYMP, PNP, NUDT1 | ESR1 3684/4885ESR2 3434/4885NR1H2 4283/4885 |
| US-20110288053-A1 | ANTIVIRAL PHOSPHONATE ANALOGS | TYMP, ITPA, PNP | ESR1 3680/4885ESR2 3740/4885NR1H2 3695/4885 |
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | SI, DAD1, FUT5 | ESR1 4782/4885ESR2 4733/4885NR1H2 4423/4885 |
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | C1R, C9, PCBP1 | ESR1 2776/4885ESR2 3955/4885NR1H2 3015/4885 |
| US-20100144868-A1 | Novel Neuroprotective Compounds and Uses Thereof | GRM2, GRIN1, GRM3 | ESR1 842/4885ESR2 383/4885NR1H2 599/4885 |
| US-20110269707-A1 | Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation | PNP, ALPP, XDH | ESR1 2848/4885ESR2 3883/4885NR1H2 2277/4885 |
| US-11700765-B2 | Organic electroluminescent materials and devices | SOD1, L1CAM, MCM2 | ESR1 210/4885ESR2 104/4885NR1H2 1782/4885 |
| US-20230233692-A1 | COMPOUNDS FOR TARGETED DEGRADATION OF RET | RET, HRAS, RBX1 | ESR1 2598/4885ESR2 1087/4885NR1H2 3094/4885 |
| US-20110039209-A1 | COMPOUND AND PHOTORESIST COMPOSITION CONTAINING THE SAME | RCOR3, RCN1, HRH4 | ESR1 649/4885ESR2 1007/4885NR1H2 695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.